before and after tirzepatide & After: My Honest 50 Lb Weight Loss Journey ✨ GLP-1 Before & After:

Semaglutide and tirzepatide share the same three approved injection sites: abdomen, thigh, and upper arm

This is decided case-by-case

This is why our program emphasizes clinical oversight

Patients taking tirzepatide may show: Improved glycemic markers : Lower fasting glucose and reduced hemoglobin A1c levels Potential lipid profile changes : Possible decreases in triglycerides and changes in cholesterol parameters Liver function parameters : Possible changes in liver enzymes in patients with fatty liver disease Kidney function monitoring : Serum creatinine and estimated glomerular filtration rate should be tracked, particularly if dehydration occurs It is important to note that tirzepatide has no known interference with standard laboratory assays and is not included in standard drug screening tests, which typically focus on substances of abuse and controlled medications

Use caution in a patient with a history of angioedema or anaphylaxis with another GLP-1 receptor agonist Acute Gallbladder Disease: Acute events of gallbladder disease such as cholelithiasis or cholecystitis have been reported in GLP-1 receptor agonist trials and postmarketing